Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists

Current Diabetes Reviews
Urd KielgastSten Madsbad

Abstract

GLP-1 (glucagon-like peptide-1) is a peptide hormone secreted from endocrine cells in the intestinal mucosa in response to meals. The major effects of GLP-1 are to increase glucose-induced insulin secretion and reduce glucagon release, but GLP-1 also inhibits gastric emptying rate and reduces appetite and bodyweight in obese subjects. In vivo studies using animal models of type 2 diabetes and in vitro studies using human islet cells have suggested that GLP-1 or GLP-1 analogues are also able to increase beta-cell mass, but in animal models of type 1 diabetes, there is much less evidence for a beta-cell preserving effect. This review summarizes the present knowledge of GLP-1 and its analogues regarding its role as a possible treatment in patients with type 1 diabetes. The studies that address the effect of GLP-1 and GLP-1 analogues on beta-cell mass in both type 2 and type 1 diabetes, as well as the potential of GLP-1 as an adjuvant therapy in islet cell transplantation, will be reviewed. Suggestions for future studies of GLP-1 treatment in type 1 diabetes may include early treatment in order to preserve beta-cell mass and prolong the remission period, but should also take a potential insulin sparing effect and changes in the ris...Continue Reading

Citations

Aug 21, 2013·Current Diabetes Reports·Jeff Unger
Mar 30, 2012·The Journal of Biological Chemistry·Michelle E KimplePatrick J Casey
Jun 4, 2011·Diabetes, Obesity & Metabolism·C G JolivaltN A Calcutt
Jun 4, 2010·Acta Physiologica·P M Hellström
Dec 1, 2010·Scandinavian Journal of Gastroenterology·Anne-Barbara WittePeter Thelin Schmidt
Nov 18, 2015·Expert Review of Clinical Pharmacology·L ØstergaardS Madsbad
Sep 29, 2015·Journal of Atherosclerosis and Thrombosis·Yoshihiro KomoharaMotohiro Takeya
Aug 22, 2015·Acta Diabetologica·Isabella CrisciStefano Del Prato
Nov 29, 2011·Pediatric Diabetes·Anne KaasUNKNOWN Hvidoere Study Group on childhood diabetes
Dec 24, 2014·Diabetes/metabolism Research and Reviews·H K ReibandK Nørgaard
Jun 8, 2013·Current Opinion in Endocrinology, Diabetes, and Obesity·Massimo Pietropaolo
Oct 30, 2015·Diabetes, Obesity & Metabolism·Sten Madsbad
Jan 8, 2019·Expert Review of Endocrinology & Metabolism·Ruchi GabaAshok Balasubramanyam
Mar 23, 2010·Endocrinology·Patricia L Brubaker
Nov 1, 2012·Expert Review of Endocrinology & Metabolism·Christophe Em De Block, Luc F Van Gaal
Sep 8, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lin-Yu WangHo-Shan Niu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
James E FoleyD E Kelley
The Journal of Clinical Endocrinology and Metabolism
Daniel J DruckerJohn B Buse
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
Judith KornerJens Juul Holst
© 2022 Meta ULC. All rights reserved